J. Lee

2 months ago | worldviewbulletin.substack.com | J. Lee |Chris Reese

Charles Spurgeon, in a sermon delivered on January 7, 1855, at New Park Street Chapel in London, stated that “the highest science, the loftiest speculation, and the mightiest philosophy that can ever engage the attention of a child of God is the name, nature, person, work, actions, and existence of the great God whom he calls his Father.” He went on to explain that contemplating God is such a vast endeavor that it leaves us overwhelmed by its immensity.

Nov 22, 2024 | cell.com | J. Lee |Alexandra T. Keinath |Erica Cianfarano |Mark Brandon

KeywordshippocampusCA1cognitive mappingremappingrepresentational similaritycalcium imagingspatial cognitionnavigationcomputational modelingplace cellsGet full text accessLog in, subscribe or purchase for full access. References1. O’Keefe, J. ∙ Nadel, L. The Hippocampus as a Cognitive Map2. Nieh, E.H. ∙ Schottdorf, M. ∙ Freeman, N.W. ... Geometry of abstract learned knowledge in the hippocampusNature. 2021; 595:80-843. Lee, J.S. ∙ Briguglio, J.J. ∙ Cohen, J.D. ...

Nov 14, 2024 | onlinelibrary.wiley.com | J. Lee

1 INTRODUCTION Uterus transplantation (UTx) is a surgery in which a uterus from a live or deceased donor is transferred to eligible women with absolute uterine factor infertility (AUFI), to enable pregnancy and childbirth.

Oct 26, 2024 | medium.com | J. Lee

J. R. Lee·Follow2 min read·--It was before I had quit my job. Maybe the exhaustion from working late the night before had taken its toll; I didn’t wake up until nearly eleven on Saturday morning. Hunger gnawed at me, making it impossible to lie around any longer, so I finally dragged myself up and started rummaging through the fridge and pantry, willing to eat just about anything. Luckily, I found a single serving of instant pasta left.

Oct 9, 2024 | nature.com | Ferdinandos Skoulidis |Ana Cobo |Meagan Montesion |Yi Yu |Natalie I. Vokes |Joseph Murray | +44 more

AbstractFor patients with advanced non-small-cell lung cancer (NSCLC), dual immune checkpoint blockade (ICB) with CTLA4 inhibitors and PD-1 or PD-L1 inhibitors (hereafter, PD-(L)1 inhibitors) is associated with higher rates of anti-tumour activity and immune-related toxicities, when compared with treatment with PD-(L)1 inhibitors alone. However, there are currently no validated biomarkers to identify which patients will benefit from dual ICB1,2.